PHARMAXIS SEEKS APPROVAL FOR ARIDOL IN SWITZERLAND

Australian pharmaceutical company Pharmaxis Ltd. has lodged the registration documents for marketing approval of its asthma management product, Aridol, with the Swiss regulatory agency for therapeutic products, Swissmedic. Trimedal AG, a specialist respiratory and allergy pharmaceutical company based in Zurich will distribute Aridol.

BioSpectrum (http://www.biospectrumasia.com/content/210706AUS1190.asp)